• Home >
  • Vital Signs The Analyst's Perspective - September 2015 Issue

Vital Signs The Analyst's Perspective - September 2015 Issue

30-Sep-2015  /  Research Code: 9A35-00-40-00-00  /  SKU: HC02617-AP-MR_16739  /  
Region: Asia Pacific

USD 450.00

* Required Fields

USD 450.00

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs discusses the acquisition of Cellular Research by Beckton Dickinson, collabaration of Illumina and Asuragen on companion diagnostics, a landmark NIH study on blood pressure management, and drug price hikes.

Table of Contents

Vital Signs The Analyst's Perspective - September 2015 IssueVital Signs - September 2015 IssueSeptember Issue




Keyword1

Keyword2

Keyword3

Related Research

Analysis of the APAC Cardiac Troponin Diagnostics Market, Forecast to 2021

Release Date : 16-Apr-18

Region : Asia Pacific

Asia-Pacific Healthcare Outlook, 2018

Release Date : 03-Apr-18

Region : Asia Pacific

Analysis of the Malaysian Endoscopy Devices Market, Forecast to 2019

Release Date : 31-Jan-18

Region : Asia Pacific

Analysis of the Indonesian Endoscopy Devices Market, Forecast to 2019

Release Date : 23-Jan-18

Region : Asia Pacific

Strategic Direction for Healthcare Reform in Japan

Release Date : 23-Jan-18

Region : Asia Pacific

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.